| University of Strathclyde, Glasgow Scotland, Bachelor of Science (B.S.) | 1972 |
| Chemistry | |
| University of Michigan, Ph.D. | 1978 |
| Organic Chemistry |
Leslie J. Browne is the Member Of The Board Of Directors at Genelabs Technology Inc.
Leslie J. Browne, Ph.D. was appointed President and Chief Executive Officer at Senesco Technologies Inc., in May 2010 and has been Director since March 2011. Dr. Browne has over 30 years of experience in the pharmaceutical industry.
Prior to joining Senesco in May 2010, he served from October 2008 to May 2010 as President and CEO, and is currently chair, of Phrixus Pharmaceuticals, Inc., a private biotech working on muscular dystrophy and heart failure.
He recently served from January 2007 to January 2009 as Chair of the New Jersey Technology Council, where he continues as a member of the board.
He also served from April 2007 to January 2009 as an Independent Director of Genelabs Technologies, which was sold to GSK.
From September 2004 to May 2008 as President, CEO & Director of Pharmacopeia, a Nasdaq listed company, where he transformed the company from a discovery contract research organization to a clinical development stage biopharmaceutical company with multiple internal development programs.
Prior to joining Pharmacopeia, Dr. Browne was the Chief Operating Officer at Iconix Pharmaceuticals, Inc., a privately-held chemogenomics company from October 2001 to July 2004.
Before Iconix, Dr. Browne held key positions at Berlex/Schering AG from 1990 to 2000, including Corporate Vice President, Berlex Laboratories, Inc.,
President of Schering Berlin Venture Corporation. In 1979.
Dr. Browne began his industrial career at Ciba-Geigy, now Novartis, where he invented fadrozole, for the treatment of breast cancer and was closely involved in the discoveries of Femara â and Diovan â, which became major products for Novartis.
Dr. Browne received his Bachelor of Science degree in Chemistry in 1972 from the University of Strathclyde, Glasgow Scotland.
He received his Ph.D. in Organic Chemistry in 1978 from the University of Michigan and his postdoctoral training as a National Institutes of Health Postdoctoral Fellow at Harvard University from January 1978 to April 1979.
Dr. Browne is an experienced executive with former CEO experience and Senior Executive level experience at large multinational, as well as development stage, life sciences companies.
He also has corporate governance experience through service on boards of other companies and organizations.
Dr. Browne’s educational background also provides him with the tools necessary to understand the science underlying our technology and how it relates to human health and agricultural applications.
